Calcium carbonate, magnesium hydroxide, and simethicone and Ranibizumab ophthalmic
Determining the interaction of Calcium carbonate, magnesium hydroxide, and simethicone and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: calcium carbonate / magnesium hydroxide / simethicone
Brand name: Mylanta Tonight
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Calcium carbonate, magnesium hydroxide, and simethicone-Ranitidine
- Calcium carbonate, magnesium hydroxide, and simethicone-Ranitidine Capsule
- Calcium carbonate, magnesium hydroxide, and simethicone-Ranitidine Hydrochloride
- Calcium carbonate, magnesium hydroxide, and simethicone-Ranitidine Injection
- Calcium carbonate, magnesium hydroxide, and simethicone-Ranitidine Suspension
- Calcium carbonate, magnesium hydroxide, and simethicone-Ranitidine Syrup
- Ranibizumab ophthalmic-Calcium Carbonate/Vit D/Vit B6/Vit B12/Folic Acid with Minerals Chew Wafers
- Ranibizumab ophthalmic-Calcium Chloride
- Ranibizumab ophthalmic-Calcium citrate
- Ranibizumab ophthalmic-Calcium Disodium Versenate
- Ranibizumab ophthalmic-Calcium Folinate Injection
- Ranibizumab ophthalmic-Calcium Glubionate